Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Gene Therapy Clinical Trials 2017 NHLBI 5U01HL121842-02 Phase II Study of AAV9-GAA Gene Transfer in Pompe Disease BYRNE, BARRY UNIVERSITY OF FLORIDA FL $564,323
Gene Therapy Clinical Trials 2017 NCI 5R01CA077544-16 Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine DIAMOND, DON BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $539,228
Gene Therapy Clinical Trials 2017 NCI 5P01CA094237-15 7530 CHIMERIC T CELLS TARGETING NEUROBLASTOMA HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $295,506
Gene Therapy Clinical Trials 2017 NICHD 5U01HD079066-03 Choroid Plexus-Directed Gene Therapy for Alpha-Mannosidosis WOLFE, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $530,182
Gene Therapy Clinical Trials 2017 NCI 5P30CA008748-51 7556 Gene Transfer RIVIERE, ISABELLE SLOAN-KETTERING INST CAN RESEARCH NY $386,610
Gene Therapy Clinical Trials 2017 NCI 5R01CA193140-02 Targeting the Ig-light chains with CAR-T cells in lymphoid tumors DOTTI, GIANPIETRO UNIV OF NORTH CAROLINA CHAPEL HILL NC $569,255
Gene Therapy Clinical Trials 2017 NCI 5R01CA164333-05 TGFbeta Blockade in MART TCR-Engineered T Cell Melanoma Immunotherapy in Man KOYA, RICHARD ROSWELL PARK CANCER INSTITUTE CORP NY $352,335
Gene Therapy Clinical Trials 2017 NCI 5R01CA186730-03 Efficient Delivery of Plasmid DNA to Achieve Appropriate Transgene Expression HELLER, RICHARD OLD DOMINION UNIVERSITY VA $353,892
Gene Therapy Clinical Trials 2017 NCI 5R01CA056821-23 Immunization Against Melanoma Differentiation Antigens WOLCHOK, JEDD SLOAN-KETTERING INST CAN RESEARCH NY $299,950
Gene Therapy Clinical Trials 2017 NEI 5U10EY024247-04 Biostatistics Center for Leber's Hereditary Optic Neuropathy: Gene Therapy Trial FEUER, WILLIAM UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $116,126
Gene Therapy Clinical Trials 2017 NIAID 5U19AI117950-03 5400 A PHASE I STUDY OF C34-CXCR4 MODIFIED CD4 T CELLS IN HIV-1 INFECTED INDIVIDUALS TEBAS, PABLO UNIVERSITY OF PENNSYLVANIA PA $678,794
Gene Therapy Clinical Trials 2017 NCI 5R01CA196975-02 First in-human PET imaging studies of NIS reporter [18F]BF4 DEGRADO, TIMOTHY MAYO CLINIC ROCHESTER MN $189,087
Gene Therapy Clinical Trials 2017 NEI 5U10EY023558-04 Leber's Hereditary Optic Neuropathy: Gene Therapy Clinical Trial GUY, JOHN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $1,160,639
Gene Therapy Clinical Trials 2017 NEI 5R24EY022023-05 rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies HAUSWIRTH, WILLIAM UNIVERSITY OF FLORIDA FL $1,613,805
Gene Therapy Clinical Trials 2017 NHLBI 5R01HL122267-02 CF Gene Therapy with adeno-associated viral vectors CEBOTARU, LIUDMILA JOHNS HOPKINS UNIVERSITY MD $664,618
Gene Therapy Clinical Trials 2017 NCI 5P01CA023766-38 6334 Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to O'REILLY, RICHARD SLOAN-KETTERING INST CAN RESEARCH NY $400,570
Gene Therapy Clinical Trials 2017 NCI 1R01CA200507-01A1 Optimizing Delivery of Oncolytic Measles Virus Strains with Cell Carriers GALANIS, EVANTHIA MAYO CLINIC ROCHESTER MN $509,698
Gene Therapy Clinical Trials 2017 NCI 5K08CA169485-05 Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W CHAPUIS, AUDE FRED HUTCHINSON CANCER RESEARCH CENTER WA $171,372
Gene Therapy Clinical Trials 2017 NIAMS 1U01AR071693-01 A Phase I Study of the Safety of AAV2/8 LSPhGAA in Late-onset Pompe Disease KOEBERL, DWIGHT DUKE UNIVERSITY NC $370,961
Gene Therapy Clinical Trials 2017 NIAID 5U01AI125051-02 Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector PAI, SUNG-YUN BOSTON CHILDREN'S HOSPITAL MA $598,418
Gene Therapy Clinical Trials 2017 NINDS 5R01NS094292-02 A Safety and Efficacy study of AAV2-hAADC for AADC deficiency BANKIEWICZ, KRYSTOF UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $883,538
Gene Therapy Clinical Trials 2017 NCI 5P50CA196510-02 8221 Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine GILLANDERS, WILLIAM WASHINGTON UNIVERSITY MO $464,275
Gene Therapy Clinical Trials 2017 NHLBI 5P01HL131471-02 7026 Clinical Trial and Immunologic aspects of muscle-directed rAAV1-AAT gene therapy FLOTTE, TERENCE UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $477,375
Gene Therapy Clinical Trials 2017 NIAID 1U01AI131310-01 Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-1 GOONETILLEKE, NILU UNIV OF NORTH CAROLINA CHAPEL HILL NC $1,012,608
Gene Therapy Clinical Trials 2017 NCI 5R35CA210039-02 Immunoprevention and immunosurveillance of human non-viral cancers FINN, OLIVERA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $922,006
Gene Therapy Clinical Trials 2017 NCI 5P50CA058236-22 5602 Tissue-Specific Radiation Sensitization of Prostate Cancer by Aptamer-Targeted siRNA Knock-Down of DNA Repair Pattiway LUPOLD, SHAWN JOHNS HOPKINS UNIVERSITY MD $224,127
Gene Therapy Clinical Trials 2017 NCI 5R01CA175517-03 Efficacy of Dendritic Cell Vaccines Targeting CMV in Glioblastoma (phase 2 DC vaccine) MITCHELL, DUANE UNIVERSITY OF FLORIDA FL $185,105
Gene Therapy Clinical Trials 2017 NCI 1R01CA217179-01 A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma. MARKERT, JAMES UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $566,814
Gene Therapy Clinical Trials 2017 NCI 5P50CA127001-10 7297 Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain Tumors FUEYO, JUAN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $307,898
Gene Therapy Clinical Trials 2017 NCI 5R01CA136551-09 Targeted therapy of B cell malignances with CAR-T cells of defined composition RIDDELL, STANLEY FRED HUTCHINSON CANCER RESEARCH CENTER WA $560,424
Gene Therapy Clinical Trials 2017 NCATS 5U01TR001814-02 Disseminating Curative Biological Therapies for Rare Pediatric Diseases WILLIAMS, DAVID BOSTON CHILDREN'S HOSPITAL MA $1,408,459
Gene Therapy Clinical Trials 2017 NHLBI 1UG1HL138641-01 Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network HARI, PARAMESWARAN MEDICAL COLLEGE OF WISCONSIN WI $175,562
Gene Therapy Clinical Trials 2017 NHLBI 2UG1HL069315-17 MSKCC BMT CTN Renewal PERALES, MIGUEL-ANGEL SLOAN-KETTERING INST CAN RESEARCH NY $193,800
Gene Therapy Clinical Trials 2017 NHLBI 2UG1HL069286-17 Abramson Cancer Center BMT/CTN Core Clinical Center STADTMAUER, EDWARD UNIVERSITY OF PENNSYLVANIA PA $177,000
Gene Therapy Clinical Trials 2017 NCI 1R44CA221461-01 INTRAVESICAL ONCOLYTIC THERAPY FOR BLADDER CANCER DIAZ, ROSA VYRIAD, INC. MN $156,755
Gene Therapy Clinical Trials 2017 NCI 261201200042I-4-26100006-1 CONTRACTOR: MAYO CLINIC; DUNNS: 006471700; PHASEI/II TRIAL OF A THERAPEUTIC DNA VACCINE FOR CHRONIC HEPATITIS C VIRUS (HCV) INFECTION;HHSN261201200042I; TASK ORDER HHSN26100006; 09/09/2014 09/08/2016 LIMBURG, PAUL MAYO CLINIC ROCHESTER MN $86,842
Gene Therapy Clinical Trials 2017 NINDS 7R01NS064607-09 OV therapy induced changes in tumor secretome and their impact on therapy KAUR, BALVEEN UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $336,875
Gene Therapy Clinical Trials 2017 NICHD 1ZIAHD008927-06 Choroid plexus-mediated gene therapy for lysosomal storage disorders KALER, STEPHEN NIH $276,121
Gene Therapy Clinical Trials 2017 NCI 1ZIABC010985-10 Gene therapy of cancer ROSENBERG, STEVEN NIH $2,268,631
Gene Therapy Clinical Trials 2017 NCI 1ZIABC011479-05 T-cell receptor gene therapy for human papillomavirus-positive cancers HINRICHS, CHRISTIAN NIH $934,220
Gene Therapy Clinical Trials 2017 NCI 1ZIASC004002-48 IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine WALDMANN, THOMAS NIH $1,524,881
Gene Therapy Clinical Trials 2017 NCI 1ZICBC011029-10 Preclinical development and clinical monitoring of adoptive immune therapy HAKIM, FRANCES NIH $585,861
Gene Therapy Clinical Trials 2017 NIAID 1ZIAAI005035-16 HIV Preventive Vaccine and Monoclonal Antibody Studies LEDGERWOOD, JULIE NIH $4,674,744
Gene Therapy Clinical Trials 2017 NIAID 1ZIAAI005047-15 Biodefense/Emerging Infection Vaccine Studies LEDGERWOOD, JULIE NIH $4,674,742
Gene Therapy Clinical Trials 2017 NIAID 1ZIAAI000991-11 Gene Therapy Clinical Trials for Chronic Granulomatous Disease KANG, ELIZABETH NIH $334,832
Gene Therapy Clinical Trials 2017 NIAID 1ZIAAI000992-11 Gene Therapy Clinical Trials for X-linked Severe Combined Immunodeficiency DE RAVIN, SUK NIH $334,832


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer